Recent Submissions

  • Multisite ileal and jejunal Crohn's, and the Heineke-Mickulicz strictureplasty

    George, B.; Murphy, P.; Ferguson, H.; Bignell, M.; Lovegrove, R.; Papettas, T.; Patel, A.; Sinha, R.; Murphy, P.; Ferguson, H.; et al. (Wiley, 2022-09)
    The video is a comprehensive teaching video on stricturing small bowel Crohn's for higher surgical trainees looking at the nature, identification, treatment and results of surgery. It is referenced, and includes operative video and stills. It lasts just over 7 minutes.
  • The L!RIC Trial and early surgery for Crohn's

    Hawker, P.; Murphy, P.; Bignell, M.; Ferguson, H.; Lovegrove, R.; Papettas, T.; Patel, A.; Sinha, R.; Hawker, P.; Murphy, P.; et al. (Wiley, 2022-09)
    This is a teaching video for surgical trainees that takes a look at the pros and cons of early surgery for Crohn's disease and the influence of the L!RIC Trial on our thinking. The video is presented by both a surgeon and a gastroenterologist. The video is referenced and contains laparoscopic and endoscopic video as well as stills. The video lasts 4 minutes.
  • Leukaemia-in-ano.

    Leung, Edmund; Wong, Ling; Wong, Ling; Wong, Ling; Surgical Services; Medical and Dental (New Zealand Medical Association, 2020-08-21)
    Fistula-in-ano is a very common surgical condition, caused by anal cryptoglandular inflammation. Most cases are idiopathic. Other causes such as Crohn's disease, trauma and malignancy are well known. Management of fistula-in-ano is largely surgical, especially if the patient is symptomatic. The goal of surgical therapy is sepsis drainage, delineate anatomy and eradicate the fistula while preserving faecal continence. Establishing the aetiology is also crucial as often a combination of specialist medical therapy is required, for example, in Crohn's disease. We report an extremely unusual case of fistula-in-ano on an elderly man with chronic lymphocytic leukaemia (CLL). Histology from the fistula track demonstrated CLL infiltration. This case, not previously reported on PubMed search, illustrates a good example of joint specialist medical (a haematologist) and surgical effort in successfully treating this symptomatic fistula-in-ano.
  • The international network on oesophageal atresia (INoEA) consensus guidelines on the transition of patients with oesophageal atresia-tracheoesophageal fistula

    Krishnan, Usha; Dumont, Michael W; Slater, Hayley; Gold, Benjamin D; Seguy, David; Bouin, Mikael; Wijnen, Rene; Dall'Oglio, Luigi; Costantini, Mario; Koumbourlis, Anastassios C; et al. (Nature Publishing Group, 2023-06-07)
    Oesophageal atresia-tracheoesophageal fistula (EA-TEF) is a common congenital digestive disease. Patients with EA-TEF face gastrointestinal, surgical, respiratory, otolaryngological, nutritional, psychological and quality of life issues in childhood, adolescence and adulthood. Although consensus guidelines exist for the management of gastrointestinal, nutritional, surgical and respiratory problems in childhood, a systematic approach to the care of these patients in adolescence, during transition to adulthood and in adulthood is currently lacking. The Transition Working Group of the International Network on Oesophageal Atresia (INoEA) was charged with the task of developing uniform evidence-based guidelines for the management of complications through the transition from adolescence into adulthood. Forty-two questions addressing the diagnosis, treatment and prognosis of gastrointestinal, surgical, respiratory, otolaryngological, nutritional, psychological and quality of life complications that patients with EA-TEF face during adolescence and after the transition to adulthood were formulated. A systematic literature search was performed based on which recommendations were made. All recommendations were discussed and finalized during consensus meetings, and the group members voted on each recommendation. Expert opinion was used when no randomized controlled trials were available to support the recommendation. The list of the 42 statements, all based on expert opinion, was voted on and agreed upon.
  • Early outcomes following EndoFLIP-tailored peroral endoscopic myotomy (POEM): the establishment of POEM services in two UK centers.

    Knight, William; Kandiah, Kaveetha; Vrakopoulou, Zoi; White, Annabel; Barbieri, Lavinia; Couch, Jennifer; DiMaggio, Francesco; Barley, Mark; Ragunath, Krish; Catton, James; et al. (Oxford University Press, 2023-07)
    Peroral endoscopic myotomy (POEM) is a safe and effective minimally invasive treatment for achalasia. Postoperative reflux rates remain high. The functional luminal imaging probe (FLIP) allows intraoperative measurement of lower esophageal distensibility during POEM. In theory, this enables a tailoring of myotomies to ensure adequate distensibility while minimizing postoperative reflux risk. Two prospectively collected POEM databases were analyzed from two UK tertiary upper GI centers. The operators in each center used FLIP measurements to ensure adequate myotomy. Outcome measures included Eckardt score (where <3 indicated clinical success) and proton-pump inhibitor use (PPI), collected at the first postoperative appointment. Length of stay was recorded as were complications. In all, 142 patients underwent POEM between 2015 and 2019. Overall, 90% (128/142) had postoperative Eckardt scores of <3 at 6 weeks. Clinical success improved to 93% (66/71) in the latter half of each series with a significantly higher rate of complete symptom resolution (53 versus 26%, P = 0.003). In all, 79% of the poor responders had previous interventions compared with 55% of responders (P = 0.09). Median post-myotomy distensibility index was 4.0 mm2/mmHg in responders and 2.9 in nonresponders (P = 0.16). Myotomy length of <7 cm was associated with 93% clinical success and 40% post op PPI use compared with 60% PPI use with longer myotomies. There were two type IIIa, two type IIIb, and one IV Clavien-Dindo complications. This is the largest series of endoluminal functional lumen imaging probe (EndoFLIP)-tailored POEM in the UK to date. The shorter myotomies, allowed through EndoFLIP tailoring, remained clinically effective at 6 weeks. Complete symptom response rates improved in the latter half of each series. More data will be needed from high-volume collaborations to decipher optimal myotomy profiles based on EndoFLIP parameters.
  • Migrated PEG balloon causing acute pancreatitis

    Saeed, Muhammad, O.; Fleck, Thomas; Awasthi, Ashish; Shekhar, Chander; Awasthi, Ashish; Saeed, Muhammad Omar; Shekhar, Chander; Gastroenterology; Surgical Services; Medical and Dental; et al. (BMJ Publishing Group, 2021-04)
    Percutaneous endoscopic gastrostomy (PEG) is a common procedure for an unsafe swallow or inability to maintain oral nutrition. When a PEG tube needs replacement, a balloon gastrostomy tube is usually placed through the same, well formed and mature tract without endoscopy. We present a patient with a rare complication related to the balloon gastrostomy tube, to raise awareness and minimise the risk of this complication in the future. A 67-year-old female patient presented to the emergency department with severe abdominal pain and vomiting. Her gastrostomy feeding tube displaced inwards, up to the feeding-balloon ports complex. After investigations, she was diagnosed with acute pancreatitis. MR cholangiopancreatography (MRCP) confirmed features of this and, interestingly, an inflated gastrostomy balloon could be seen abutting the major and minor ampullae. The patient confirmed that the PEG tube had been changed to a balloon gastrostomy tube some time ago, but the external fixation plate (external bumper) had been loose lately, with the tube repeatedly moving inwards. She admitted that, 1 day before admission, the PEG tube had receded into the stomach and could not be pulled out with a gentle tug. After reviewing the MRCP images, the balloon was deflated, and the tube retracted. Once correctly placed, the balloon was reinflated, and her symptoms improved over the next 2 days.